Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 35,402 Shares of Stock

Anthem, Inc. (NASDAQ:ANTX) Director Robin Shane Readnour sold 35,402 shares of Anthem stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $6.01, for a total transaction of $212,766.02. Following the completion of the sale, the director directly owned 565,592 shares of the company’s stock, valued at approximately $3,399,207.92. This trade represents a 5.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Anthem Price Performance

NASDAQ ANTX opened at $5.96 on Thursday. The stock has a market capitalization of $224.93 million, a price-to-earnings ratio of -5.57 and a beta of -0.99. Anthem, Inc. has a 1-year low of $1.00 and a 1-year high of $7.19. The business’s fifty day moving average price is $5.11 and its 200-day moving average price is $3.95.

Anthem (NASDAQ:ANTX) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ANTX shares. Leerink Partners raised Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target for the company in a report on Thursday, May 14th. Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Guggenheim initiated coverage on shares of Anthem in a report on Monday, July 20th. They set a “buy” rating and a $9.00 price target on the stock. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Anthem in a research report on Monday, July 6th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $9.00.

Institutional Investors Weigh In On Anthem

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vivo Capital LLC purchased a new position in Anthem during the first quarter valued at $10,785,000. Commodore Capital LP purchased a new stake in Anthem in the 1st quarter worth $7,981,000. Spruce Street Capital LP bought a new position in shares of Anthem during the 1st quarter valued at about $5,576,000. Ally Bridge Group NY LLC purchased a new position in shares of Anthem during the first quarter valued at about $1,800,000. Finally, Seven Fleet Capital Management LP bought a new position in Anthem during the first quarter valued at approximately $683,000. Institutional investors own 90.47% of the company’s stock.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.